R. Vabre et al. / Dyes and Pigments 105 (2014) 145e151
147
128.3,127.4,125.9,122.2,120.1,115.7, 71.3, 58.9, 45.8, 29.8. MS (ESþ)
2.2.16. (E)-6-(pyrrolidin-1-yl)-9-(tetrahydro-2H-pyran-2-yl)-8-
m/z (%) : 454.4 (100) [M þ H]þ. HRMS (ESI) calcd for C24H23F3N5O
[(M þ H)þ] 455.1855, found 455.1846.
(4(trifluoromethyl)styryl)-9H-purine (6b)
Yellow solid (68%) : 1H NMR (300 MHz, CDCl3)
d 8.33 (s,1H), 7.79
(d, J ¼ 16.0 Hz, 1H), 7.70e7.63 (m, 4H), 7.58 (d, J ¼ 16.0 Hz, 1H), 5.97
2.2.10. (E)-4-(2-(7-benzyl-4-(benzyl(methyl)amino)-7H-pyrrolo
(d, J ¼ 11.1 Hz,1H), 4.32e4.28 (m, 3H), 3.84e3.77 (m, 3H), 2.18e2.05
[2,3-d]pyrimidin-6-yl)vinyl)benzonitrile (3g)
(m, 6H), 1.92e1.64 (m, 4H). 13C NMR (75 MHz, CDCl3)
d 152.6, 150.4,
Yellow oil (78%) : 1H NMR (300 MHz, CDCl3)
d
8.40 (s, 1H), 7.70
146.0, 139.9, 133.1, 129.9, 127.2, 125.8, 120.1, 118.9, 82.4, 69.4, 32.1,
30.2, 25.3, 23.2. MS (ESþ) m/z (%) : 444.3 (100) [M þ H]þ. HRMS
(ESI) calcd for C23H25F3N5O [(M þ H)þ] 444.2011, found 444.2022.
(d, J ¼ 16.0 Hz, 1H), 7.48e7.63 (m, 4H), 7.37e7.28 (m, 8H), 7.21 (d,
J ¼ 6.7 Hz, 2H), 7.02 (d, J ¼ 15.8 Hz,1H), 5.54 (s, 2H), 3.50 (s, 2H),1.65
(s, 3H). 13C NMR (75 MHz, CDCl3)
d 154.5, 152.9, 152.3, 145.7, 140.4,
138.0, 136.3, 133.8, 132.7, 129.2, 128.7, 128.2, 127.9, 127.6, 126.8,
120.5, 118.8, 116.9, 111.9, 45.7, 43.6, 30.3. MS (ESþ) m/z (%) : 457.4
(100) [M þ H]þ. HRMS (ESI) calcd for C29H25N6 [(M þ H)þ] 457.2141,
found 457.2144.
2.2.17. (E)-N-(4-methoxybenzyl)-9-(tetrahydro-2H-pyran-2-yl)-8-
(4-(trifluoromethyl)styryl)-9H-purin-6-amine (6c)
Yellow solid (84%) : 1H NMR (300 MHz, CDCl3)
d 8.41 (s, 1H), 7.76
(d, J ¼ 16.1 Hz, 1H), 7.65 (s, 4H), 7.55 (d, J ¼ 16.1 Hz, 1H), 7.32 (d,
J ¼ 8.6 Hz, 2H), 6.87 (d, J ¼ 8.7 Hz, 2H), 6.14 (bs, 1H), 5.95 (dd,
J ¼ 11.1, 2.4 Hz, 1H), 4.80 (bs, 2H), 4.31 (d, J ¼ 9.9 Hz, 1H), 3.84e3.79
(m, 4H), 2.23e2.07 (m, 2H), 1.95e1.64 (m, 4H). 13C NMR (75 MHz,
2.2.11. (E)-N,7-dibenzyl-N-methyl-6-(4-(trifluoromethyl)styryl)-
7H-pyrrolo[2,3-d]pyrimidin-4-amine (3h)
Yellow oil (88%) : 1H NMR (300 MHz, CDCl3)
d
8.40 (s, 1H), 7.74
CDCl3) d 159.2, 154.2, 153.0, 147.5, 139.6, 134.2, 130.8, 130.5, 130.4,
(d, J ¼ 15.9 Hz, 1H), 7.60e7.50 (m, 4H), 7.37e7.28 (m, 8H), 7.23 (d,
129.4, 127.4, 125.9, 122.3, 119.5, 118.5, 114.2, 82.7, 69.5, 55.4, 43.6,
32.2, 25.4, 23.3. MS (ESþ) m/z (%) : 510.3 (100) [M þ H]þ. HRMS
(ESI) calcd for C27H27F3N5O2 [(M þ H)þ] 510.2117, found 510.2123.
J ¼ 6.4 Hz, 2H), 7.01 (d, J ¼ 15.9 Hz,1H), 5.54 (s, 2H), 3.51 (s, 2H), 1.66
(s, 3H). 13C NMR (75 MHz, CDCl3)
d 154.4, 152.6, 152.1, 145.9, 139.3,
137.9, 136.2, 134.2, 130.6, 130.2, 129.0, 128.6, 128.0, 127.8, 127.3,
127.2, 126.7, 125.7, 122.1, 120.2, 115.8, 45.5, 43.4, 30.1. MS (ESþ) m/z
(%) : 500.4 (100) [M þ H]þ. HRMS (ESI) calcd for C29H25F3N5
[(M þ H)þ] 500.2062, found 500.2059.
2.2.18. (E)-4-(2-(6-((4-methoxybenzyl)amino)-9H-purin-8-yl)
vinyl)benzonitrile (7a)
Yellow solid (99%) : 1H NMR (300 MHz, DMSO-d6)
d 8.20 (bs,
2H), 7.88e7.80 (m, 4H), 7.64 (d, J ¼ 16.7 Hz, 1H), 7.35e7.29 (m, 3H),
2.2.12. 6-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (4)
6.86 (d, J ¼ 8.2 Hz, 2H), 4.65 (bs, 2H), 3.70 (s, 3H). 13C NMR (75 MHz,
Pale yellow solid (89%) : 1H NMR (300 MHz, CDCl3)
d
8.76 (s, 1H),
DMSO-d6) d 158.1,152.7,147.3,140.2,132.8,132.2,131.9,128.6,127.6,
8.35 (s, 1H), 5.80 (dd, J ¼ 10.2, 2.5 Hz, 1H), 4.23e4.18 (m, 1H), 3.80
(td, J ¼ 11.4, 3.1 Hz, 1H), 2.20e2.00 (m, 3H), 1.85e1.67 (m, 3H).
Spectroscopic data were in agreement with those reported in the
literature [23].
120.9, 118.8, 113.6, 110.6, 55.0, 29.0. MS (ESþ) m/z (%) : 383.4 (100)
[M þ H]þ. HRMS (ESI) calcd for C29H19N6O [(M þ H)þ] 383.1620,
found 383.1625.
2.2.19. (E)-6-(pyrrolidin-1-yl)-8-(4-(trifluoromethyl)styryl)-9H-
purine (7b)
2.2.13. (E)-6-chloro-9-(tetrahydro-2H-pyran-2-yl)-8-(4-
(trifluoromethyl)styryl)-9H-purine (5a)
Yellow solid (93%) : 1H NMR (300 MHz, DMF-d7)
d 13.18 (bs, 1H),
Yellow solid (36%) : 1H NMR (300 MHz, CDCl3)
d
8.70 (s, 1H), 8.15
8.21 (s, 1H), 7.94 (d, J ¼ 8.1 Hz, 2H), 7.83e7.75 (m, 3H), 7.43 (d,
(d, J ¼ 16.6 Hz, 1H), 7.75e7.68 (m, 4H), 7.60 (d, J ¼ 16.0 Hz, 1H), 6.04
J ¼ 16.6 Hz, 1H), 4.21 (bs, 2H), 3.70 (bs, 2H), 2.02 (bs, 4H). 13C NMR
(d, J ¼ 11.8, 1H), 4.34 (d, J ¼ 11.0 Hz, 1H), 3.82 (t, J ¼ 11.5 Hz, 1H),
(75 MHz, DMF-d7) d 152.9, 152.6, 152.32, 152.29, 152.2, 147.0, 140.4,
2.30e1.78 (m, 6H). 13C NMR (75 MHz, CDCl3)
d
153.1, 152.2, 151.4,
131.9, 127.6, 125.9, 121.2, 120.8, 22.5, 13.7. MS (ESþ) m/z (%) : 360.4
(100) [M þ H]þ. HRMS (ESI) calcd for C18H17F3N5 [(M þ H)þ]
360.1436, found 360.1441.
149.7, 138.9, 138.4, 131.4, 127.9, 126.1, 126.0, 122.2, 117.1, 83.2, 69.6,
31.9, 25.3, 23.2. MS (ESþ) m/z (%) : 431.2 (100) [M þ Na]þ. HRMS
(ESI) calcd for C19H17ClF3N4O [(M þ H)þ] 409.1043, found 409.1046.
2.2.20. (E)-N-(4-methoxybenzyl)-8-(4-(trifluoromethyl)styryl)-9H-
purin-6-amine (7c)
2.2.14. (E)-4-(2-(6-chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-
purin-8-yl)vinyl)benzonitrile (5b)
Yellow solid (87%) : 1H NMR (300 MHz, DMF-d7)
d 8.23 (s, 1H),
Yellow solid (38%) : 1H NMR (300 MHz, CDCl3)
d
8.70 (s, 1H), 8.12
7.92 (d, J ¼ 8.1 Hz, 1H), 7.81e7.74 (m, 3H), 7.58e7.51 (m, 2H), 7.43e
(d, J ¼ 16.0 Hz, 1H), 7.72 (m, 4H), 7.62 (d, J ¼ 16.0 Hz, 1H), 6.04 (dd,
J ¼ 11.0, 2.6 Hz, 1H), 4.34 (dd, J ¼ 12.0, 3.6 Hz, 1H), 3.83 (td, J ¼ 11.5,
3.8 Hz, 1H), 2.32e2.09 (m, 2H), 2.00e1.75 (m, 4H). 13C NMR
7.35 (m, 3H), 6.91e6.85 (m, 3H), 4.80 (bs, 2H), 3.76 (s, 3H). 13C NMR
(75 MHz, DMF-d7)
d d 158.8, 153.1,
13C NMR (75 MHz, DMF-d7)
152.1, 147.7, 140.2, 132.5, 129.4, 128.9, 127.7, 126.4, 125.9, 125.8,
124.9, 122.8, 120.6, 113.7, 54.9, 22.5. MS (ESþ) m/z (%) : 426.4 (100)
[M þ H]þ. HRMS (ESI) calcd for C22H19F3N5O [(M þ H)þ] 426.1542,
found 426.1534.
(75 MHz, CDCl3) d 152.7, 152.2, 151.5, 149.9, 139.8, 137.8, 132.8, 131.4,
128.2, 118.6, 118.1, 112.9, 83.3, 69.6, 32.0, 25.3, 23.2. MS (ESþ) m/z
(%) : 282.1 (100) [M-THP]þ, 366.2 (60) [M þ H]þ. HRMS (ESI) calcd
for C19H17ClN5O [(M þ H)þ] 366.1122, found 366.1137.
3. Results and discussion
2.2.15. (E)-4-(2-(6-((4-methoxybenzyl)amino)-9-(tetrahydro-2H-
pyran-2-yl)-9H-purin-8-yl)vinyl)benzonitrile (6a)
During our previous work on developing new synthetic meth-
odologies in the area of direct CeH bond functionalization, new 6-
amino- or 6-thio-8-styrylpurines were synthesized through a key
C-8 direct alkenylation step (Fig. 1) [20].
First, the optical properties of these newly synthesized com-
pounds were studied (results not shown). Among those 19 com-
Yellow solid (82%) : 1H NMR (300 MHz, CDCl3)
d 8.40 (s, 1H),
7.76e7.55 (m, 6H), 7.30 (d, J ¼ 8.6 Hz, 2H), 6.86 (d, J ¼ 8.7 Hz, 2H),
6.19 (bs, 1H), 5.96 (dd, J ¼ 11.0, 2.4 Hz, 1H), 4.80 (bs, 2H), 4.30 (d,
J ¼ 12.9 Hz, 1H), 3.84e3.79 (m, 4H), 2.24e2.04 (m, 2H), 1.96e1.68
(m, 4H). 13C NMR (75 MHz, CDCl3)
d 159.1, 154.2, 153.2, 147.1, 140.5,
133.6, 132.7, 130.5, 129.3, 127.6, 119.5, 118.8, 114.1, 111.9, 82.7, 69.5,
55.4, 43.5, 32.3, 25.4, 23.2. MS (ESþ) m/z (%) : 467.3 (100) [M þ H]þ.
HRMS (ESI) calcd for C27H27N6O2 [(M þ H)þ] 467.2195, found
467.2206.
pounds, eight were fluorescent in dichloromethane with a
quantum yield higher than 0.32. From a structural point of view,
they bear either electron withdrawing group on the para position of
the styryl group or an amino substituent on the 6 position of the